We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$548M
AUM Growth
+$7.66M
Cap. Flow
-$12M
Cap. Flow %
-2.19%
Top 10 Hldgs %
32.65%
Holding
154
New
7
Increased
23
Reduced
102
Closed
2

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$4.98M
2
STE icon
Steris
STE
+$4.1M
3
FCX icon
Freeport-McMoran
FCX
+$2.26M
4
ADI icon
Analog Devices
ADI
+$2.16M
5
JNJ icon
Johnson & Johnson
JNJ
+$1.91M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Industrials 19.03%
3 Technology 17.84%
4 Energy 9.49%
5 Utilities 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAS
101
DELISTED
American Capital Ltd
ACAS
$1.2M 0.22%
78,158
-2,000
-2% -$29.8K
CMC icon
102
Commercial Metals
CMC
$7.8B
$1.17M 0.21%
+67,450
New +$1.25M
BNS icon
103
Scotiabank
BNS
$108B
$1.11M 0.2%
17,764
-1,769
-9% -$102K
NSLR
104
Neostellar Capital Corp
NSLR
$269M
$1.11M 0.2%
161,556
+68,996
+75% +$430K
PEP icon
105
PepsiCo
PEP
$195B
$1.04M 0.19%
11,653
CBST
106
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$1.02M 0.19%
14,625
-450
-3% -$30.6K
FCX icon
107
Freeport-McMoran
FCX
$88.6B
$990K 0.18%
27,125
-66,000
-71% -$2.26M
COHU icon
108
Cohu
COHU
$2B
$987K 0.18%
+92,252
New +$972K
TLM
109
DELISTED
TALISMAN ENERGY INC
TLM
$944K 0.17%
89,060
-19,700
-18% -$206K
ROP icon
110
Roper Technologies
ROP
$38.7B
$943K 0.17%
6,459
-600
-8% -$83.7K
TEL icon
111
TE Connectivity
TEL
$62.1B
$856K 0.16%
13,850
-950
-6% -$56.9K
ECNS icon
112
iShares MSCI China Small-Cap ETF
ECNS
$63.9M
$847K 0.15%
18,600
CVGW
113
DELISTED
Calavo Growers
CVGW
$837K 0.15%
24,750
-4,280
-15% -$140K
TTEK icon
114
Tetra Tech
TTEK
$8.7B
$830K 0.15%
150,905
-14,000
-8% -$76.6K
PWE
115
DELISTED
Penn West Energy Petroleum Ltd
PWE
$705K 0.13%
72,250
-8,055
-10% -$74.7K
MOS icon
116
The Mosaic Company
MOS
$7.34B
$697K 0.13%
14,100
-300
-2% -$14.8K
SWZ
117
Swiss Helvetia Fund
SWZ
$76.7M
$688K 0.13%
47,200
-6,800
-13% -$97.7K
EEMV icon
118
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.41B
$685K 0.13%
+11,400
New +$675K
GXC icon
119
State Street SPDR S&P China ETF
GXC
$453M
$670K 0.12%
8,900
-300
-3% -$21.9K
BSV icon
120
Vanguard Short-Term Bond ETF
BSV
$44.7B
$609K 0.11%
7,580
VNM icon
121
VanEck Vietnam ETF
VNM
$479M
$599K 0.11%
28,800
+700
+2% +$14.3K
CVE icon
122
Cenovus Energy
CVE
$51.6B
$572K 0.1%
17,666
-2,500
-12% -$74.4K
CHMG icon
123
Chemung Financial Corp
CHMG
$395M
$548K 0.1%
18,546
-4,096
-18% -$116K
MKSI icon
124
MKS Inc
MKSI
$19.3B
$517K 0.09%
16,550
-5,400
-25% -$156K
CHXX
125
DELISTED
EGSHARES CHINA INFRASTRUCTURE ETF
CHXX
$511K 0.09%
30,250
-19,200
-39% -$321K

Similar funds

John G. Ullman & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, John G. Ullman & Associates held 154 positions worth $548M, up 1.4% from $540M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q2 2014 filing shows 7 new, 23 increased, 102 reduced and 2 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 47,646 shares worth $2.45M. The largest sale was Exelon, an estimated $4.98M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q2 2014 buy was State Street SPDR S&P Biotech ETF: 47,646 shares worth $2.45M.
  • John G. Ullman & Associates added most to Otter Tail in Q2 2014, an estimated $3.75M increase.
  • John G. Ullman & Associates's biggest Q2 2014 reduction was Exelon, cutting an estimated $4.98M.
  • John G. Ullman & Associates fully exited Halliburton in Q2 2014, selling an estimated $707K.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $548M portfolio in Q2 2014.
  • John G. Ullman & Associates opened 7 new positions and closed 2 in Q2 2014.
  • John G. Ullman & Associates's portfolio value rose 1.4% quarter-over-quarter to $548M.

Based on John G. Ullman & Associates's 13F filing for Q2 2014, filed 18 Jul 2014.